Polyphenols as antioxidant/pro-oxidant compounds and donors of reducing species: relationship with human antioxidant metabolism

CMC Andrés, JM Pérez de la Lastra, CA Juan, FJ Plou… - Processes, 2023 - mdpi.com
In this review, we have focused mainly on the study of their antioxidant and pro-oxidant
capacity, and the analysis of the oxidation of the catechol group to o-quinone. The redox …

The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers

TJ Monks, DC Jones - Current drug metabolism, 2002 - ingentaconnect.com
Quinones are ubiquitous in nature and constitute an important class of naturally occurring
compounds found in plants, fungi and bacteria. Human exposure to quinones therefore …

Formation and biological targets of quinones: cytotoxic versus cytoprotective effects

JL Bolton, T Dunlap - Chemical research in toxicology, 2017 - ACS Publications
Quinones represent a class of toxicological intermediates, which can create a variety of
hazardous effects in vivo including, acute cytotoxicity, immunotoxicity, and carcinogenesis …

Human Family 1–4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update

SP Rendic, FP Guengerich - Archives of toxicology, 2021 - Springer
This is an overview of the metabolic activation of drugs, natural products, physiological
compounds, and general chemicals by the catalytic activity of cytochrome P450 enzymes …

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine

KM Bertelsen, K Venkatakrishnan, LL Von Moltke… - Drug Metabolism and …, 2003 - ASPET
Paroxetine, a selective serotonin reuptake inhibitor, is a potent inhibitor of cytochrome P450
2D6 (CYP2D6) activity, but the mechanism of inhibition is not established. To determine …

Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk

IMCM Rietjens, MG Boersma, H van der Woude… - Mutation Research …, 2005 - Elsevier
The present review focuses on the mechanisms of mutagenic action and the carcinogenic
risk of two categories of botanical ingredients, namely the flavonoids with quercetin as an …

Myristicin and elemicin: potentially toxic alkenylbenzenes in food

ME Götz, B Sachse, B Schäfer, A Eisenreich - Foods, 2022 - mdpi.com
Alkenylbenzenes represent a group of naturally occurring substances that are synthesized
as secondary metabolites in various plants, including nutmeg and basil. Many of the …

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development

SF Zhou, ZW Zhou, LP Yang… - Current medicinal …, 2009 - ingentaconnect.com
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions …

AS Kalgutkar, RS Obach, TS Maurer - Current drug metabolism, 2007 - ingentaconnect.com
Cytochrome P450 constitute a superfamily of heme-containing enzymes that catalyze the
oxidative biotransformation of structurally diverse xenobiotics including drugs. Inhibition of …

Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation

G Galati, MY Moridani, TS Chan, PJ O'Brien - Free Radical Biology and …, 2001 - Elsevier
GSH was readily depleted by a flavonoid, H2O2, and peroxidase mixture but the products
formed were dependent on the redox potential of the flavonoid. Catalytic amounts of …